XIAP
E3 ubiquitin-protein ligase XIAP
Also known as: API3, BIRC4, hILP, ILP-1, XIAP_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P98170
- Gene
- XIAP
- Ensembl
- ENSG00000101966
- Chromosome
- X
- Canonical length
- 497 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a protein that belongs to a family of apoptotic suppressor proteins. Members of this family share a conserved motif termed, baculovirus IAP repeat, which is necessary for their anti-apoptotic function. This protein functions through binding to tumor necrosis factor receptor-associated factors TRAF1 and TRAF2 and inhibits apoptosis induced by menadione, a potent inducer of free radicals, and interleukin 1-beta converting enzyme. This protein also inhibits at least two members of the caspase family of cell-death proteases, caspase-3 and caspase-7. Mutations in this gene are the cause of X-linked lymphoproliferative syndrome. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 2 and 11.[provided by RefSeq, Feb 2011]
Canonical amino-acid sequenceUniProt
497 residues, UniProt reviewed canonical sequence.
>P98170|XIAP
1 MTFNSFEGSK TCVPADINKE EEFVEEFNRL KTFANFPSGS PVSASTLARA GFLYTGEGDT
61 VRCFSCHAAV DRWQYGDSAV GRHRKVSPNC RFINGFYLEN SATQSTNSGI QNGQYKVENY
121 LGSRDHFALD RPSETHADYL LRTGQVVDIS DTIYPRNPAM YSEEARLKSF QNWPDYAHLT
181 PRELASAGLY YTGIGDQVQC FCCGGKLKNW EPCDRAWSEH RRHFPNCFFV LGRNLNIRSE
241 SDAVSSDRNF PNSTNLPRNP SMADYEARIF TFGTWIYSVN KEQLARAGFY ALGEGDKVKC
301 FHCGGGLTDW KPSEDPWEQH AKWYPGCKYL LEQKGQEYIN NIHLTHSLEE CLVRTTEKTP
361 SLTRRIDDTI FQNPMVQEAI RMGFSFKDIK KIMEEKIQIS GSNYKSLEVL VADLVNAQKD
421 SMQDESSQTS LQKEISTEEQ LRRLQEEKLC KICMDRNIAI VFVPCGHLVT CKQCAEAVDK
481 CPMCYTVITF KQKIFMSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against XIAP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 20 nTPM
Expression across tissuesHPA
Tissue
- retina: 20 nTPM
- parathyroid gland: 18 nTPM
- thyroid gland: 15 nTPM
- colon: 12 nTPM
- kidney: 12 nTPM
- liver: 12 nTPM
Single-cell type
- neutrophils: 254 nCPM
- esophageal apical cells: 191 nCPM
- rod photoreceptor cells: 185 nCPM
- myonuclei: 181 nCPM
- urothelial cells: 151 nCPM
- choroid plexus epithelial cells: 148 nCPM
Immune cell
- basophil: 8.2 nTPM
- neutrophil: 4.9 nTPM
- memory CD8 T-cell: 3.3 nTPM
- gdT-cell: 3 nTPM
- naive B-cell: 2.9 nTPM
- MAIT T-cell: 2.8 nTPM
Brain region
- choroid plexus: 33 nTPM
- white matter: 28 nTPM
- spinal cord: 25 nTPM
- hypothalamus: 25 nTPM
- midbrain: 25 nTPM
- medulla oblongata: 24 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about XIAP.
Disease | AllUniProt
Conditions XIAP is implicated in, by any mechanism.
- Lymphoproliferative syndrome, X-linked, 2 (XLP2) MIM:300635
Disease | GeneticClinVar
73 pathogenic / likely-pathogenic of 514 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- X-linked lymphoproliferative disease due to XIAP deficiency
- Inborn genetic diseases
- XIAP-related disorder
- Nonpapillary renal cell carcinoma
- Thyroid cancer, nonmedullary, 1
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.37
- gnomAD pLI
- 0.92
- gnomAD missense Z
- 1.49
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- copper ion homeostasis
- defense response to bacterium
- DNA damage response
- negative regulation of apoptotic process
- negative regulation of tumor necrosis factor-mediated signaling pathway
- neuron apoptotic process
- nucleotide-binding oligomerization domain containing 1 signaling pathway
- nucleotide-binding oligomerization domain containing 2 signaling pathway
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of canonical Wnt signaling pathway
- positive regulation of JNK cascade
- positive regulation of protein linear polyubiquitination
- positive regulation of protein ubiquitination
- positive regulation of type I interferon production
- protein K63-linked ubiquitination
- quinolinate biosynthetic process
- regulation of apoptosis involved in tissue homeostasis
- regulation of apoptotic process
- regulation of BMP signaling pathway
- regulation of cell cycle
- regulation of inflammatory response
- regulation of innate immune response
- regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway
- response to lipopolysaccharide
- Wnt signaling pathway
Molecular functions
- cysteine-type endopeptidase inhibitor activity
- cysteine-type endopeptidase inhibitor activity involved in apoptotic process
- identical protein binding
- protein serine/threonine kinase binding
- ubiquitin protein ligase activity
- ubiquitin-protein transferase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of XIAP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads XIAP as an antibody target. Whether an autoantibody or antibody against XIAP could matter depends on whether native XIAP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
XIAP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label XIAP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...